TABLE 1.

Hypoglycaemic events^a

Timeframe	Arm	Variable	N	Mean	SE	Median	Minimumb	Maximumb
On drug	Exenatide ER	Level 1 hypoglycaemia event rate	39	2.07	0.44	1.00	0	11.33
		Level 2 hypoglycaemia event rate	39	1.82	0.50	0.67	0	13.00
		Total event rate	39	3.89	0.88	1.33	0	21.67
	Placebo	Level 1 hypoglycaemia event rate	35	2.60	0.54	1.60	0	13.00
		Level 2 hypoglycaemia event rate	35	2.00	0.43	0.80	0	10.50
		Total event rate	35	4.59	0.94	2.33	0	23.50
Off drug	Exenatide ER	Level 1 hypoglycaemia event rate	37	1.09	0.29	0.17	0	8.33
		Level 2 hypoglycaemia event rate	37	0.74	0.19	0.33	0	5.00
		Total event rate	37	1.83	0.45	0.50	0	11.17
	Placebo	Level 1 hypoglycaemia event rate	26	1.81	0.53	0.50	0	12.50
		Level 2 hypoglycaemia event rate	26	1.62	0.55	0.50	0	13.17
		Total event rate	26	3.43	1.05	1.00	0	25.67

^aHypoglycaemia was defined using American Diabetes Association criteria (level 1 between 55 mg/dL (3.05 mmol/L) and 70 mg/dL (3.89 mmol/L), level 2 hypoglycaemia ≤55mg/dL (3.05 mmol/L).¹⁷

^bEvents/study month/person.